1. IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte–Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System
   Nancy Adriana Espinoza-Sánchez et al, 2017, Front. Immunol. CrossRef
2. Regulat-INGs in tumors and diseases: focus on ncRNAs
   Marjorie Gournay et al, 2019, Cancer Letters CrossRef
3. The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders
   Yang Du et al, 2019, Biosci. Rep. CrossRef
4. miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA
   Francesca Maria Orlandella et al, 2019, Endocrine CrossRef
5. MicroRNA suppression of stress-responsive NDRG2 during dexamethasone treatment in skeletal muscle cells
   Bilal A. Mir et al, 2019, BMC Mol and Cell Biol CrossRef
6. Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44+CD24- stemness
   Evgeny V. Denisov et al, 2017, Oncotarget CrossRef
7. A Bioinformatic Pipeline Places STAT5A as a miR-650 Target in Poorly Differentiated Aggressive Breast Cancer
   Eric López-Huerta et al, 2020, IJMS CrossRef
8. Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity
   Mayra Cecilia Suárez-Arriaga et al, 2021, Cancers CrossRef
9. Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancer.
   Aymen Shatnawi et al, 2021, Adv Cancer Res CrossRef
10. Functions and underlying mechanisms of miR-650 in human cancers
    Yuanshuai Su et al, 2022, Cancer Cell Int CrossRef
11. Elucidating miRNA Function in Cancer Biology via the Molecular Genetics’ Toolbox
    Adam Azlan et al, 2022, Biomedicines CrossRef